These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37279390)

  • 1. Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
    Vila-Castelar C; Chen Y; Langella S; Lopera F; Zetterberg H; Hansson O; Dage JL; Janelidzde S; Su Y; Chen K; Pluim McDowell C; Martinez JE; Ramirez-Gomez L; Garcia G; Aguillon D; Baena A; Giraldo-Chica M; Protas HD; Ghisays V; Rios-Romenets S; Tariot PN; Blennow K; Reiman EM; Quiroz YT
    Alzheimers Dement; 2023 Sep; 19(9):4127-4138. PubMed ID: 37279390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
    Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O
    JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
    Aguillon D; Langella S; Chen Y; Sanchez JS; Su Y; Vila-Castelar C; Vasquez D; Zetterberg H; Hansson O; Dage JL; Janelidze S; Chen K; Fox-Fuller JT; Aduen P; Martinez JE; Garcia G; Baena A; Guzman C; Johnson KA; Sperling RA; Blennow K; Reiman EM; Lopera F; Quiroz YT
    Alzheimers Dement; 2023 Jun; 19(6):2585-2594. PubMed ID: 36571821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
    Vila-Castelar C; Guzmán-Vélez E; Pardilla-Delgado E; Buckley RF; Bocanegra Y; Baena A; Fox-Fuller JT; Tirado V; Muñoz C; Giraldo M; Acosta-Baena N; Rios-Romenets S; Langbaum JB; Tariot PN; Lopera F; Reiman EM; Quiroz YT
    J Alzheimers Dis; 2020; 77(4):1743-1753. PubMed ID: 32925067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.
    Guzmán-Vélez E; Zetterberg H; Fox-Fuller JT; Vila-Castelar C; Sanchez JS; Baena A; Garcia-Ospina G; Aguillon D; Pardilla-Delgado E; Gatchel JR; Sperling RA; Johnson K; Reiman EM; Blennow K; Lopera F; Quiroz YT
    Alzheimers Dement; 2021 May; 17(5):813-821. PubMed ID: 33527648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.
    Saloner R; VandeVrede L; Asken BM; Paolillo EW; Gontrum EQ; Wolf A; Lario-Lago A; Milà-Alomà M; Triana-Baltzer G; Kolb HC; Dubal DB; Rabinovici GD; Miller BL; Boxer AL; Casaletto KB; Kramer JH
    Alzheimers Dement; 2024 Jan; 20(1):376-387. PubMed ID: 37639492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
    Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
    Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.
    Vila-Castelar C; Tariot PN; Sink KM; Clayton D; Langbaum JB; Thomas RG; Chen Y; Su Y; Chen K; Hu N; Giraldo-Chica M; Tobón C; Acosta-Baena N; Luna E; Londoño M; Ospina P; Tirado V; Muñoz C; Henao E; Bocanegra Y; Alvarez S; Rios-Romenets S; Ghisays V; Goradia D; Lee W; Luo J; Malek-Ahmadi MH; Protas HD; Lopera F; Reiman EM; Quiroz YT;
    Alzheimers Dement; 2022 Nov; 18(11):2272-2282. PubMed ID: 35103388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
    Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
    Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
    Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    Baena A; Bocanegra Y; Torres V; Vila-Castelar C; Guzmán-Vélez E; Fox-Fuller JT; Gatchel JR; Sánchez J; Pluim CF; Ramirez-Gómez L; Martínez J; Pineda D; Lopera F; Quiroz YT
    J Alzheimers Dis; 2021; 82(4):1809-1822. PubMed ID: 34219716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms.
    Armstrong GW; Kim LA; Vingopoulos F; Park JY; Garg I; Kasetty M; Silverman RF; Zeng R; Douglas VP; Lopera F; Baena A; Giraldo M; Norton D; Cronin-Golomb A; Arboleda-Velasquez JF; Quiroz YT; Miller JB
    JAMA Ophthalmol; 2021 Jan; 139(1):49-56. PubMed ID: 33180114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
    Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
    Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gutierrez Gomez M; Langois CM; Langbaum JB; Roontiva A; Thiyyagura P; Lee W; Ayutyanont N; Lopez L; Moreno S; Muñoz C; Tirado V; Acosta-Baena N; Fagan AM; Giraldo M; Garcia G; Huentelman MJ; Tariot PN; Lopera F; Reiman EM
    JAMA Neurol; 2015 Mar; 72(3):316-24. PubMed ID: 25580592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
    Johansson C; Thordardottir S; Laffita-Mesa J; Rodriguez-Vieitez E; Zetterberg H; Blennow K; Graff C
    Brain; 2023 Mar; 146(3):1132-1140. PubMed ID: 36626935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.